Medicaid Is Pulling Back on ABA Therapy. Here’s What That Signals for Practices.

For more than a decade, applied behavior analysis (ABA) has been one of the most widely covered and reimbursed interventions for children with autism spectrum disorder. As Medicaid coverage expanded across the country, so did the number of families accessing care—and the cost of providing it.

Today, that landscape is changing. Across the country, state Medicaid programs are reducing reimbursement rates, capping therapy hours, tightening authorization requirements, and increasing oversight of ABA services. For practices that rely on Medicaid, these changes aren’t just policy updates—they’re influencing reimbursement, operations, and long-term planning.

Why Medicaid Spending on ABA Exploded in the First Place

ABA is a relatively new Medicaid benefit. The federal government directed states to cover autism treatment in 2014 under the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) mandate, but ABA specifically wasn’t consistently covered until 2022. Once it was, spending didn’t just grow—it compounded.

According to a 2026 Wall Street Journal analysis of national Medicaid billing records, direct state Medicaid payments to ABA providers more than tripled, rising from $660 million in 2019 to $2.2 billion in 2023. During the same period, the number of companies providing ABA services nearly doubled. Much of that growth reflects increased awareness of autism, broader insurance coverage, and more families gaining access to medically necessary care. At the same time, the rapid increase in spending has prompted many state Medicaid programs to take a closer look at how ABA services are authorized, delivered, and reimbursed.

Why States Are Cutting Now

States aren’t responding to a single issue. Instead, several factors have contributed to greater scrutiny of how ABA services are authorized, delivered, and reimbursed, including:

Billing and documentation. Federal and state audits have identified improper Medicaid payments related to ABA services in several states. For example, an HHS Office of Inspector General (OIG) audit found Indiana’s Medicaid program made improper payments for some autism therapy claims and recommended stronger oversight. Similar findings in other states have prompted many Medicaid programs to increase scrutiny of billing practices, documentation, and reimbursement. Additional audits remain ongoing.

Greater scrutiny of treatment hours. Many states are taking a closer look at how ABA hours are authorized, with increased emphasis on demonstrating medical necessity and individualized treatment plans rather than relying on standardized hour recommendations. As a result, some states have introduced hour caps, expanded prior authorization requirements, or implemented additional clinical review for higher levels of care.

High-profile investigations. Recent investigations and enforcement actions have drawn greater attention to Medicaid-funded ABA services. In response, many states have expanded auditing, strengthened documentation requirements, and tightened oversight of reimbursement and authorization policies.

A Growing Clinical Question About “More Hours”: Expectations around ABA treatment intensity are evolving. While intensive therapy remains appropriate for some children, there is growing emphasis on ensuring that recommended hours are based on individual clinical need rather than standardized benchmarks. That shift is influencing how some payers approach prior authorization, documentation, and ongoing review of ABA services.

Together, these developments have prompted many Medicaid programs to take a more measured approach to ABA reimbursement. 

What States Are Actually Doing

The specifics vary by state, but the overall direction is similar. Rather than eliminating Medicaid coverage for ABA, many states are changing how services are reimbursed, authorized, and monitored.

Reimbursement: States including North Carolina, New York, Nebraska, Indiana, Colorado, and Georgia have reduced reimbursement rates or updated ABA fee schedules.

Authorization: Many states have expanded prior authorization requirements and increased documentation needed to demonstrate medical necessity.

Provider standards: Some states have introduced provider accreditation requirements or revised billing policies to strengthen oversight and align with updated coding guidance.

While each state’s approach is different, the broader trend is consistent: Medicaid programs are placing greater emphasis on individualized treatment recommendations, stronger clinical documentation, and greater accountability for how ABA services are authorized, delivered, and reimbursed.

What This Signals, Beyond the Immediate Cuts

These changes shouldn’t be viewed as a shift away from ABA itself. Rather, they reflect a broader effort by Medicaid programs to balance access to care with long-term sustainability, consistency, and accountability.

As states refine reimbursement policies, authorization requirements, and documentation standards, the expectation is increasingly that treatment recommendations are individualized, medically necessary, and well supported. For ABA practices, that means strong clinical documentation and thoughtful care planning are becoming just as important operationally as they are clinically.

What This Means for ABA Practices Moving Forward

Individualized, outcomes-based care is no longer just a clinical best practice—it’s becoming a compliance requirement. Blanket 30–40-hour treatment plans applied uniformly across a caseload are exactly what auditors, and increasingly state guidelines, are now built to catch. Documentation that clearly links hours to individual need, updated regularly, is the strongest protection a practice has.

Compliance infrastructure is now a growth requirement, not just a risk-management line item. States are moving toward mandatory accreditation, standardized fee schedules, and stricter authorization review. Practices that build clean documentation, credentialing, and billing practices now will be better positioned as more states adopt these standards, rather than scrambling to retrofit them later.

Payer diversification matters more than it did five years ago. Practices heavily concentrated in Medicaid, in a small number of states, or with a single dominant payer are the most exposed to sudden rate or policy shifts. A more diversified payer mix and geographic footprint reduce single-point failure risk.

Demand for the therapy itself isn’t going away. EPSDT still mandates Medicaid coverage of medically necessary ABA for eligible children, and any changes to that mandate would require congressional action. Diagnosis rates continue to rise, and families continue to seek treatment. The organizations facing the most risk aren’t the ones providing legitimate, individualized care, but the ones whose growth depended solely on the reimbursement environment.

Conclusion

As states continue to refine coverage, reimbursement, and oversight, ABA practices will need to adapt alongside those changes. Organizations that emphasize individualized care, strong clinical documentation, and operational resilience will be better positioned to navigate an increasingly complex landscape.